Clinical TrialsSearch results
Number of results: 888
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan
- Cardiopulmonary arrest on arrival(CPAOA)
- Teikyo University School of Medicine, Teikyo University Hospital
- 2008-10-01
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Gemcitabine Plus Paclitaxel versus Gemcitabine alone in Patients with Recurrent or Advanced Urothelial Cancer previously Treated With Cisplatin-based Chemotherapy: A randomized Phase II study
- Urothelial cancer
- Teikyo University
- 2009-10-01
Recruiting
- Mucosta trial
- Patients with dry eye complicated by Sjogren's syndrome
- Tatsumi Tomoaki
- 2022-08-27
Completed
- Simultaneous subthreshold retinal-photocoagulation and intravitreal injection of VEGF inhibitors for diabetic macular edema
- diabetic macular edema
- Tatsumi Tomoaki
- 2019-03-05
Completed
- Weekly liposomal doxorubicin and cisplatin chemotherapy for patients with ovarian cancer, phase I study
- ovarian cancer
- Tate Shinichi
- 2020-04-10
Completed
- Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Hepatocellular Carcinoma
- Tanigawa Takahiko
- 2021-03-23
Completed
- Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
- Metastatic Colorectal Cancer
- Tanaka Yoshiyuki
- 2020-10-12
Other
- Japanese Gynecologic Oncology Group 3020 (ECO trial)
- Epithelial ovarian cancer
- TANABE HIROSHI
- 2019-03-25
Completed
- First in patients of a New PET Probe FEDAC
- Malignant tumors(solid tumors)
- Tamura Kentaro
- 2022-07-07